SLNO News

Latest breaking news and updates for SLNO stock.

Track all markets on TradingView

SLNO Investors Have Opportunity to Join Soleno Therapeutics, Inc. Fraud Investigation with the Schall Law Firm

(NASDAQ:SLNO) LOS ANGELES--(BUSINESS WIRE)---- $SLNO--SLNO Investors Have Opportunity to Join Soleno Therapeutics, Inc. Fraud Investigation with the Schall Law Firm

Could this lawsuit trigger additional regulatory scrutiny or impact existing partnerships and pipeline milestones for Soleno Therapeutics? What is the timeline for the investigation and potential legal actions, and how might that affect short‑term trading volatility? How likely is a material settlement or judgment from the fraud investigation, and what magnitude could it have on SLNO's valuation?
Lawsuits
3 days ago
Read more businesswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO

(NASDAQ:SLNO) NEW YORK, Sept. 3, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Soleno Therapeutics, Inc. ("Soleno" or the "Company") (NASDAQ: SLNO). Such inve...

Are there any precedent cases in the biotech sector where similar investor lawsuits led to regulatory scrutiny or product development delays? What potential financial exposure or settlement costs could arise from the claims, and how will that impact the company’s balance sheet and earnings outlook? How might the lawsuit investigation affect Soleno Therapeutics' short‑term stock volatility and trading volume?
Lawsuits
10 days ago
Read more prnewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO

NEW YORK, Aug. 25, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Soleno Therapeutics, Inc. ("Soleno" or the "Company") (NASDAQ: SLNO). Such investors are advi...

How might the lawsuit affect investor sentiment and short‑term trading volumes for SLNO? What is the expected timeline for the investigation and any subsequent legal actions? What is the potential financial impact of the lawsuit on Soleno Therapeutics' balance sheet and cash flow?
Lawsuits
19 days ago
Read more prnewswire

Rosen Law Firm Encourages Soleno Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – SLNO

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Soleno Therapeutics, Inc. (...

Are there any potential catalysts or upcoming corporate events that could mitigate or exacerbate the impact of the investigation on the company's valuation? How might this news affect Soleno Therapeutics' short‑term stock volatility and trading volume? What is the likelihood and timeline of the securities class action investigation resulting in a material settlement or judgment?
Legal
19 days ago
Read more businesswire

Soleno Therapeutics (SLNO) Drops Amid Critical Scorpion Report -- Hagens Berman

SAN FRANCISCO, Aug. 20, 2025 /PRNewswire/ -- On August 15, 2025, shares in Soleno Therapeutics, Inc. (NASDAQ: SLNO) experienced a significant drop following the release of a highly critical report ...

Is there precedent for similar biotech legal challenges, and how did those companies' valuations recover over time? What potential financial exposure could arise from Hagens Berman’s shareholder rights action against SLNO? How will the critical Scorpion report and ensuing lawsuit affect Soleno Therapeutics' short‑term stock volatility?
Lawsuits
24 days ago
Read more prnewswire

Soleno Therapeutics Provides Update on U.S. Launch of VYKAT(TM) XR and Reports Second Quarter 2025 Financial Results

REDWOOD CITY, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare dise...

Does the company have sufficient liquidity to fund the launch and continued pipeline development without additional financing? What are the key catalysts or risk factors in the next 12‑18 months that could drive the stock price volatility for SLNO? How does Soleno's competitive landscape look – what are rival therapies and how might they affect VYKAT™ XR's market share?
Earnings
about 1 month ago
Read more globenewswire